Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

K-ras gene mutation+2

Not recruiting

Registered drugNo placebo

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years

Contact Research Centre

Graft versus host disease+1

Not recruiting

Investigational

Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Itolizumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Peripheral spondyloarthritis

Not recruiting

Registered drug

Study on Peripheral Spondyloarthritis: Comparing Methotrexate Disodium and Golimumab for Early Remission in Adult Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Golimumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Burkitt's lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Interstitial lung disease

Not recruiting

Investigational

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational

Belgium

Participants:65+ years
Substances:Bi 1015550

Contact Research Centre

Neoplasm

Not recruiting

InvestigationalNo placebo

Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Omx-0407

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

InvestigationalNo placebo

Study of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Investigational

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Enasidenib Mesilate

Contact Research Centre

B precursor type acute leukaemia

Not recruiting

Registered drugNo placebo

Study on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Find therapies in clinical trials near you – page 12

234 trials match your criteria

K-ras gene mutation+2

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Graft versus host disease+1

Study of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant

Plasma cell myeloma

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Peripheral spondyloarthritis

Study on Peripheral Spondyloarthritis: Comparing Methotrexate Disodium and Golimumab for Early Remission in Adult Patients

Plasma cell myeloma

Study Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant

Burkitt's lymphoma

Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

Interstitial lung disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Neoplasm

Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors

Myelodysplastic syndrome

Study of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes

Acute myeloid leukaemia+1

Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

B precursor type acute leukaemia

Study on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia

Neoplasm

Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.